Poonawalla's legacy in vaccines and philanthropy

TL;DR

Cyrus Poonawalla of Serum Institute blends business with social impact through affordable vaccines.
SII vaccines have saved over 30 million lives from diseases like polio, measles, and Covid-19.
Family businesses enable long-term investments in health access for low-income countries.

The story at a glance

Cyrus S Poonawalla, founder and chairman of Serum Institute of India, received the Philanthropic Leadership award at the ET Family Business Awards for advancing health access. The article highlights SII's vaccines and the Villoo Poonawalla Foundation's work in healthcare and education. This coverage ties to the awards event on April 17, 2026.

Key points

SII pursues a 'Health For All' vision, focusing on affordability, quality, and access in vaccines for low- and middle-income countries.
Vaccines target polio, measles, diphtheria, tetanus, meningitis, and Covid-19, reducing disease burden globally.
Villoo Poonawalla Foundation, set up in 2012, supports healthcare, education, and community development for underserved groups.
Family-owned firms like SII offer long-term views, responsibility, research investment, and trust with partners.
Poonawalla views the award as both an honour and a duty to keep contributing to public health.

Details and context

Serum Institute started with the idea that life-saving vaccines should reach everyone, regardless of income or location. This approach has built its global role, backed by science investments and partnerships.

The foundation expands preventive care and infrastructure in areas where access is limited. Poonawalla stresses how family control ensures continuity over decades, key in healthcare where quick profits often rule.[[1]](https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/poonawallas-clear-shot-at-access-for-all-via-route-social/articleshow/130317107.cms)

Key quotes

"The founding values of Serum Institute have always been affordability, quality, and access," said Poonawalla. "We started with the belief that life-saving vaccines should not be limited by income or geography."

"Family-owned enterprises bring a long-term perspective and a strong sense of responsibility," Poonawalla said. "In healthcare, this allows for investment in research, capacity building, and innovation."

Why it matters

Affordable vaccines from firms like SII cut disease in poor countries, supporting global health goals. For businesses and investors, it shows family models can mix profit with impact in pharma. Watch SII's next moves in new vaccines or foundation projects, as they could shape access trends.